At long last, successes are piling up. The two Columbus institutions have generated not only revenue, but IPOs, several acquisitions, job-creating startups and an FDA-approved gene therapy that has normally non-effusive scientists using the term cure.
Click here to read the complete story.
Story excerpt provided by Columbus Business First.
Written by Carrie Ghose.
Originally published April 22, 2021.